Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 89 citing Hochster: Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated.... (0.09 sec) 

Adverse effects of antiretroviral therapy

- sbinfecto.org.br [PDF] 
A Carr, DA Cooper - The Lancet, 2000 - Elsevier
Several factors have combined to increase our attention on the toxicity of
HAART. First, since HIV-1 eradication seems unlikely with current therapy, 1 and
2 HAART will need to be indefinite for clinical benefits to be preserved. ...
Cited by 701 - Related articles - BL Direct - All 11 versions

Ganciclovir


CS Crumpacker - The New England Journal of Medicine, 1996 - nejm.highwire.org
Ganciclovir is a nucleoside analogue of guanosine, a homologue of acyclovir, and
the first antiviral drug to be effective in the treatment of cytomegalovirus
(CMV) disease in humans. 1 , 2 , 3 , 4 It inhibits not only all the ...
Cited by 256 - Related articles - All 4 versions

Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant


DC Musch, DF Martin, JF Gordon, MD Davis, … - The New England journal of medicine, 1997 - nejm.highwire.org
Results The median time to progression of retinitis was 221 days with the
1-µg-per-hour implant (75 eyes), 191 days with the 2-µg-per-hour implant (71
eyes), and 71 days with ganciclovir administered intravenously (76 eyes; ...
Cited by 156 - Related articles - BL Direct - All 8 versions

Ocular manifestations of HIV infection.


DA Jabs - Transactions of the American Ophthalmological Society, 1995 - pubmedcentral.nih.gov
OBJECTIVE: To evaluate the frequency of ocular complications and the clinical
outcomes of these complications in patients with various stages of HIV
infection. METHODS: Retrospective review of all HIV-infected patients seen ...
Cited by 139 - Related articles - BL Direct - All 4 versions

Drug interactions in patients infected with human immunodeficiency virus


SC Piscitelli, C Flexner, JR Minor, MA Polis, … - Clinical infectious diseases, 1996 - jstor.org
Patients with AIDS who are receiving optimal medical care, including combination
therapy with antiretroviral agents and more effective prophylaxis and therapy
for opportunistic infections and neoplasms, are surviving longer. However, ...
Cited by 127 - Related articles - BL Direct - All 3 versions

(S)-1-[3-hydroxy-2-(phosphonylmethoxy) propyl] cytosine (cidofovir): results of a phase I/II …


JP Lalezari, WL Drew, E Glutzer, C James, D … - The Journal of Infectious Diseases, 1995 - jstor.org
CMV effect was observed with all cidofovir regimens ^3.0 mg/kg. The
dose-limiting toxicity of cidofovir was dose- and schedule-dependent
nephrotoxicity. Four of 20 patients had serum creati- nine levels 5*2.0 ...
Cited by 88 - Related articles - BL Direct - All 3 versions

Antiviral therapy: current concepts and practices.

- nih.gov
B Bean - Clinical Microbiology Reviews, 1992 - Am Soc Microbiol
Page 1. CLINICAL MICROBIOLOGY REVIEWS, Apr. 1992, p. 146-182 Vol. 5, No. 2
0893-8512/92/020146-37$02.00/0 Copyright © 1992, American Society for Microbiology ...
Cited by 63 - Related articles - All 6 versions

Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS …


DT Dieterich, MA Poles, EA Lew, PE Mendez, … - The Journal of infectious diseases, 1993 - jstor.org
Ten patients with AIDS and progressive cytomegalovirus disease were treated with
ganciclovir and foscarnet concurrently. The patients had received ganciclovir
and foscarnet monotherapy a median of 330 days before receiving combination ...
Cited by 63 - Related articles - BL Direct - All 3 versions

Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell …

- jbc.org
M Adachi, J Sampath, L Lan, D Sun, P … - Journal of Biological Chemistry, 2002 - ASBMB
The multidrug resistance protein MRP4, a member of the ATP-binding cassette
superfamily, confers resistance to purine-based antiretroviral agents. However,
the antiviral agent ganciclovir (GCV) has not been shown to be a substrate ...
Cited by 58 - Related articles - BL Direct - All 4 versions

Recent advances in the management of AIDS-related opportunistic infections

- annals.org
HC Lane, BE Laughon, J Falloon, JA Kovacs, … - Annals of internal medicine, 1994 - Am Coll Physicians
Secondary infections remain the leading cause of death in patients with the
acquired immunodeficiency syndrome (AIDS).Dealing with the rapidly evolving
spectrum of infectious problems seen in patients with AIDS requires ...
Cited by 51 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google